← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 5, 2022Last known activity
Mar 21, 2024
Timeline
2020s
- Apr 16, 2021
Pentixapharm AG— Acquired
Drugs by trial phase (3 distinct, 5 trials)
Phase 3 (1 own, 2 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (2)
- NCT06240741CollaboratorPhase 3Mar 21, 2024
- NCT05222269Lead sponsorPhase 2Oct 5, 2022
Details
- Last known activity
- Mar 21, 2024